Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin microdialysis in subcutaneous adipose tissue in morbidly obese and non-obese surgical patients
NL-OMON36673Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Dec 2010
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of cefazolin and nadroparin in surgical site infection (SSI) and venous thromboembolism (VTE), sponsored by St. Antonius Ziekenhuis. Primary endpoints: Cefazolin concentrations in subcutaneous adipose tissue, Total and unbound cefazolin concentration in plasma and 1 more. Started Dec 2010; status: active, not recruiting.
02
Drugs
cefazolinnadroparin
03
Conditions
surgical site infection (SSI)venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON36673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36673.